Also, we concluded that PAAD patients with higher SDC1 expression occupied poorer OS (HR = 1.6, P=0.018) and DFS (HR = 1.8, P=0.012), accurately (Figures 5(m) and 5(n)). This evidence concerns the gene SDC1 and pancreatic adenocarcinoma.